PRESS RELEASE published on 08/27/2025 at 06:47, 8 months 28 days ago Aroundtown announces H1 2025 results demonstrating a strong balance sheet, paving the way for opportunistic growth Aroundtown announces strong H1 2025 results with stable net rental income and adjusted EBITDA. Balance sheet shows decreased LTV to 40% and successful bond issuances, aiming for growth opportunities Growth Opportunities Balance Sheet Aroundtown Bond Issuances H1 2025 Results
PRESS RELEASE published on 08/27/2025 at 06:46, 8 months 28 days ago EQS-Adhoc: Dexus Finance Pty Limited: Change in substantial holding for DXC Dexus Finance Pty Limited announces change in substantial holding for DXC. The ASX release provides details on Dexus's interest in Dexus Convenience Retail REIT Dexus Finance Pty Limited Dexus ASX Release DXC Substantial Holding
PRESS RELEASE published on 08/27/2025 at 06:45, 8 months 28 days ago Aroundtown announces H1 2025 results demonstrating a strong balance sheet, paving the way for opportunistic growth Aroundtown announces strong H1 2025 results with stable net rental income and decreased LTV, paving the way for growth. CFO transition announced Balance Sheet CFO Transition Aroundtown H1 2025 Results Opportunistic Growth
PRESS RELEASE published on 08/27/2025 at 06:30, 8 months 28 days ago Accelleron Industries AG: Accelleron, propelled by high demand and market share gains, reports outstanding half-year results Accelleron Industries AG reports outstanding half-year results with revenues increasing by 20.3%, operational EBITA rising to USD 154.9 million, and net income at USD 114.7 million Revenues Net Income Half-year Results Accelleron Industries AG EBITA
PRESS RELEASE published on 08/27/2025 at 00:40, 8 months 28 days ago XCF Global Announces Receipt of Nasdaq Listing Delinquency Letter, Provides Update of Expected Q2 2025 Form 10-Q Filing XCF Global, Inc. receives Nasdaq non-compliance notice for delayed Quarterly Report filing. Company has 60 days to submit a plan for compliance Quarterly Report Nasdaq Aviation Non-Compliance XCF Global Inc.
PRESS RELEASE published on 08/26/2025 at 23:00, 8 months 28 days ago Sun Peak Provides an Update on the Shire Project Sun Peak Metals Corp. declares force majeure for Shire VMS and Gold Project in Ethiopia, suspends fieldwork to support mining regulations. Company maintains commitment to exploration and shareholder value creation Exploration Sun Peak Metals Corp. Ethiopia Force Majeure Mining Regulations
PRESS RELEASE published on 08/26/2025 at 22:50, 8 months 28 days ago Electric Metals Announces Positive PEA for the 100% US Domestic North Star Manganese Project Providing 100% U.S. Domestic Supply of HPMSM, Post-Tax NPV10% of US$1.39 Billion, IRR of 43.5%, and 23-Month Payback Electric Metals (USA) Limited announces robust results of Preliminary Economic Assessment for the North Star Manganese Project in Emily, Minnesota, potentially becoming the first U.S. domestic producer of high-purity manganese sulphate monohydrate, aligning with Presidential Executive Orders on Critical Minerals Critical Minerals Electric Metals Manganese Project North Star Presidential Executive Orders
PRESS RELEASE published on 08/26/2025 at 22:43, 8 months 28 days ago Health Canada Approves MedMira's Reveal(R) Rapid TP Test - Urgent New Tool In The Battle Against Syphilis MedMira receives Health Canada approval for Reveal® TP (Syphilis) Antibody Test, the fastest standalone syphilis screening device in Canada. The test offers immediate results from a finger-prick blood sample, aiding in early detection and treatment Clinical Trials Health Canada Approval MedMira Reveal TP Syphilis Screening
PRESS RELEASE published on 08/26/2025 at 22:15, 8 months 28 days ago Organto Foods Announces Second Quarter 2025 Financial Results Organto Foods Inc. reports strong financial results for Q2 2025, with sales up 291% year-over-year. Company shows significant gross profit increase and improved operating costs efficiency Financial Results Sales Increase Organto Foods Inc. Profit Growth Q2 2025
PRESS RELEASE published on 08/26/2025 at 22:05, 8 months 28 days ago Protagonist Therapeutics to Participate in Multiple Investment Bank Conferences in September 2025 Protagonist Therapeutics announced CEO's participation in investment bank conferences in September. Company's advanced Phase 3 clinical development and future plans highlighted Protagonist Therapeutics Phase 3 Clinical Development NDA Submission Investment Bank Conferences Drug Discovery Programs
Published on 05/23/2026 at 19:45, 13 hours 11 minutes ago Golden Minerals Announces Closing of Equity Financing
Published on 05/23/2026 at 03:15, 1 day 5 hours ago UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Published on 05/23/2026 at 03:00, 1 day 5 hours ago Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/23/2026 at 02:25, 1 day 6 hours ago Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Published on 05/23/2026 at 02:25, 1 day 6 hours ago Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Published on 05/24/2026 at 05:55, 3 hours 1 minute ago The 26th CIFIT to Open in Xiamen This September, Preceded by Successful Guangzhou Roadshow
Published on 05/24/2026 at 05:35, 3 hours 21 minutes ago CGTN: Xizang at 75: Development and culture create a 'miracle on Earth'
Published on 05/23/2026 at 16:30, 16 hours 26 minutes ago HiFS 2026: Upgrading Four Major Digital Finance Solutions to Accelerate Financial Institutions Toward Agentic Banking
Published on 05/23/2026 at 15:57, 16 hours 59 minutes ago EQS-Adhoc: Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
Published on 05/22/2026 at 22:05, 1 day 10 hours ago Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 18:05, 1 day 14 hours ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 1 day 20 hours ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
Published on 05/22/2026 at 08:30, 2 days ago Eiffage is building four solar power plants for the NOOR Atlas programme in Morocco
Published on 05/21/2026 at 17:45, 2 days 15 hours ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS